OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Economic evaluation of sintilimab versus docetaxel as second-line treatment for patients with advanced or metastatic squamous non-small-cell lung cancer in China: a model-based cost-effectiveness analysis
Mochong Liao, Shuo Kang
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 24, Iss. 1, pp. 161-166
Closed Access | Times Cited: 2
Mochong Liao, Shuo Kang
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 24, Iss. 1, pp. 161-166
Closed Access | Times Cited: 2
Showing 2 citing articles:
Cost-effectiveness analysis of the tislelizumab versus docetaxel for advanced or metastatic non-small-cell lung cancer in China
Xiaoyu Zhang, Xiongxiong Fan, Jin Zhang, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Xiaoyu Zhang, Xiongxiong Fan, Jin Zhang, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial
Heng Xiang, Kehui Meng, Mei-Yu Wu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024) Vol. 24, Iss. 8, pp. 1043-1051
Closed Access | Times Cited: 1
Heng Xiang, Kehui Meng, Mei-Yu Wu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024) Vol. 24, Iss. 8, pp. 1043-1051
Closed Access | Times Cited: 1
